InterCure Share Holder Equity 2022-2024 | INCR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

InterCure share holder equity from 2022 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

InterCure share holder equity from 2022 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$200B
Stryker (SYK)	$141B
Boston Scientific (BSX)	$128B
Medtronic (MDT)	$113B
EssilorLuxottica (ESLOY)	$112.7B
Lonza Group Ag (LZAGY)	$45.3B
Haleon (HLN)	$43.5B
GE HealthCare Technologies (GEHC)	$40.4B
ResMed (RMD)	$36.5B
Terumo (TRUMY)	$30.3B
Koninklijke Philips (PHG)	$25.9B
Zimmer Biomet Holdings (ZBH)	$21.6B
Baxter (BAX)	$18.4B
Insulet (PODD)	$17.2B
Smith & Nephew SNATS (SNN)	$10.8B
Bio-Rad Laboratories (BIO)	$10.4B
BellRing Brands (BRBR)	$8.9B
Demant (WILYY)	$8.4B
Lantheus Holdings (LNTH)	$6.1B
Haemonetics (HAE)	$4.4B
ICU Medical (ICUI)	$4.4B
TG Therapeutics (TGTX)	$4.3B
Prestige Consumer Healthcare (PBH)	$4B
Envista Holdings (NVST)	$3.7B
Perrigo (PRGO)	$3.7B
Neogen (NEOG)	$3.4B
Agios Pharmaceuticals (AGIO)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.9B
QuidelOrtho (QDEL)	$2.6B